Latest market price
81.26
+0.32+0.40%
LMATQT37LeMaitre Vascular, Inc.·NASDAQ
81.26+0.40%
TA
Loading chart...
Screen all →
Snapshot
Index—P/E28.51EPS (ttm)2.85Insider Own8.17%Shs Outstand22.87MPerf Week-3.62%
Market Cap1.86BForward P/E25.56EPS next Y3.18Insider Trans-3.13%Shs Float21.29MPerf Month2.91%
Enterprise Value1.67BPEG—EPS next Q0.69Short Float8.34%Perf Quarter-23.18%
Income66.00MP/S7.09EPS this Y16.54%Short Ratio5.41Perf Half Y-27.14%
Sales262.00MP/B4.42EPS next Y10.66%ROA10.25%Short Interest1.78MPerf YTD0.20%
Book/sh18.37P/C4.94EPS next 5Y—ROE16.42%52W High118.01 -31.14%Perf Year-8.23%
Cash/sh16.44P/FCF25.46EPS past 3/5Y39.41% 19.36%ROIC9.76%52W Low78.22 3.89%Perf 3Y79.11%
Dividend Est.1.00 (1.23%)EV/EBITDA17.76Sales past 3/5Y15.56% 14.15%Gross Margin72.90%Volatility3.04% 2.76%Perf 5Y47.18%
Dividend TTM0.95 (1.17%)EV/Sales6.37EPS Y/Y TTM38.35%Oper. Margin29.46%ATR (14)2.32Perf 10Y308.96%
Dividend Ex-DateAug 20, 2026Quick Ratio13.96Sales Y/Y TTM11.49%Profit Margin25.02%RSI (14)46.36Recom2.30
Dividend Gr. 3/5Y16.96% 16.05%Current Ratio16.31EPS Q/Q23.33%SMA20-1.34%Beta0.49Target Price115.00
Payout31.21%Debt/Eq0.45Sales Q/Q9.38%SMA500.09%Rel Volume0.83Prev Close80.94
Employees651LT Debt/Eq0.45EarningsNov 04SMA200-13.96%Avg Volume327.05KPrice81.26
IPO DateOct 19, 2006Option/ShortYes / YesEPS/Sales Surpr.-8.27% -1.53%Net Debt/EBITDA-2.01Volume270,720Change0.40%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-06-26ReiteratedBarringtonOutperform$120 → $95
May-06-26ReiteratedLake StreetBuy$110 → $135
May-06-26ReiteratedBarrington ResearchOutperform$120
Nov-10-25ReiteratedCantor FitzgeraldNeutral$96 → $95
Nov-05-25ResumedRoth CapitalBuy$108
Aug-06-25UpgradeBarrington ResearchMarket Perform → Outperform
Feb-28-25ReiteratedLake StreetBuy$110
Feb-28-25DowngradeBarrington ResearchOutperform → Market Perform
Oct-15-24InitiatedCantor FitzgeraldNeutral$96
Aug-20-24ReiteratedJMP SecuritiesMarket Outperform$100
Latest News· Times ET
Oct-31-26
Oct-22-26
Oct-12-26
Oct-06-26
Oct-01-26
Sep-24-26
Sep-23-26
Sep-21-26
Sep-08-26
Sep-04-26
Sep-02-26
Aug-28-26
Aug-27-26
Aug-14-26
Aug-13-26
Company

Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot. Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure. Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001. It is headquartered in Burlington, Massachusetts.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue262250220193—————
Cost of Goods Sold Incl. D&A71716966—————
Gross Profit191179151127—————
Selling, General and Administrative Excl. Other100968373—————
Research and Development16141617—————
Other Operating Expense-2100—————
Operating Income77685237—————
Interest Expense4500—————
Unusual Expense
—————————
Non-Operating Income (Expense)131253—————
Net Income Before Taxes85755739—————
Income Taxes1917139—————
Consolidated Net Income66584430—————
Net Income From Continuing Operations66584430—————
Net Income66584430—————
EPS (Recurring)2.902.551.961.36—————
EPS (Basic, Before Extraordinaries)2.902.551.961.36—————
EPS (Diluted)2.852.521.931.34—————
EBITDA94916749—————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio28.5132.1847.7442.36—————
Price To Sales Ratio7.137.469.216.47—————
Gross Margin72.9071.6068.6465.80—————
Operating Margin29.3927.2023.6419.17—————
Net Margin25.1923.2020.0015.54—————
Shares Outstanding23232222—————
Market Capitalization1,8691,8652,0271,249—————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$123.18$110.64$98.09$85.55$73.01● Close Price0.00M4.26M8.52M12.77M17.03MUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Roush John ADirectorSep 01 '26Option Exercise48.603,444167,3787,386Sep 03
Kamke Trent GSenior V. P., OperationsMay 08 '26Sale107.002,928313,2873,749May 11
LeMaitre George WChairman and CEOMay 08 '26Sale108.6927,8813,030,4001,430,019May 11
LeMaitre George WChairman and CEOMay 07 '26Sale107.6418,6002,002,0131,457,900May 11
Jasinski Lawrence JDirectorMay 07 '26Option Exercise65.922,858188,4128,657May 11
Jasinski Lawrence JDirectorMay 07 '26Sale110.003,943433,7304,714May 11
Ross Bridget ADirectorMay 07 '26Option Exercise48.155,044242,8828,986May 11
Ross Bridget ADirectorMay 07 '26Sale111.105,044560,3663,942May 11
Pellegrino Joseph P JRDirectorApr 22 '26Option Exercise35.482,941104,34715,021Apr 23
Kamke Trent GSenior V. P., OperationsMar 11 '26Option Exercise35.482,62593,1359,302Mar 13
Roberts David BPresident and DirectorMar 11 '26Sale107.683,312356,58614,667Mar 13
Kamke Trent GSenior V. P., OperationsMar 11 '26Sale108.502,625284,8136,677Mar 13
LeBlanc Dorian PaulChief Financial OfficerMar 10 '26Option Exercise0.00202,400Mar 12
LeMaitre George WChairman and CEOMar 02 '26Sale107.8155,9306,030,0201,476,500Mar 02
Roberts David BPresident and DirectorFeb 27 '26Sale106.808,464903,95817,979Mar 02
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.